Viewing Study NCT06643260


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-27 @ 11:18 PM
Study NCT ID: NCT06643260
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-29
First Post: 2024-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Sponsor: Can-Fite BioPharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module